Cox-1 Polyclonal Antibody

PTGS1 is one of two genes encoding similar enzymes that catalyze the conversion of arachinodate to prostaglandin. Prostaglandin-endoperoxide synthase 1 regulates angiogenesis in endothelial cells, and is inhibited by nonsteroidal anti-inflammatory drugs such as aspirin. Based on its ability to function as both a cyclooxygenase and as a peroxidase, prostaglandin-endoperoxide synthase 1 has been identified as a moonlighting protein. Prostaglandin-endoperoxide synthase 1 may promote cell proliferation during tumor progression. Alternative splicing results in multiple transcript variants.

The Cox-1 Polyclonal Antibody is a highly specific and sensitive antibody that has been designed for use in a variety of research applications. This antibody has been developed using advanced techniques and is capable of detecting Cox-1 protein in a range of samples, including tissue lysates, cell lysates, and serum.

The Cox-1 Polyclonal Antibody is produced using high-quality materials and has been rigorously tested to ensure its specificity and sensitivity. This antibody is ideal for use in a range of research applications, including Western blotting, immunohistochemistry, and immunofluorescence.

The Cox-1 Polyclonal Antibody is supplied in a convenient format, making it easy to use in a variety of experimental settings. This antibody is also available in a range of sizes, allowing researchers to choose the most appropriate product for their specific needs.

Overall, the Cox-1 Polyclonal Antibody is a reliable and effective tool for researchers studying Cox-1 protein expression and function. Its high specificity and sensitivity make it an ideal choice for a wide range of research applications.